LYSAKARE 25 g/25 g, solution for infusion bag, 1000 ml
Active ingredients: L-arginine, Arginine hydrochloride, Lysine hydrochloride, L-lysine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusionbag, 1000 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LYSAKARE 25 g/25 g, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 poche PVC suremballée(s)/surpochée(s) de 1000 mL
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 May 2020
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65395602CIP75506874CIP133400955068747Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LYSINEsolution | 20 g · une poche de 1000 mL | FT |
| ARGININEsolution | 20,7 g · une poche de 1000 mL | FT |
| CHLORHYDRATE D'ARGININEsolution | 25 g · une poche de 1000 mL | SA |
| CHLORHYDRATE DE LYSINEsolution | 25 g · une poche de 1000 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.